2WNC image
Entry Detail
PDB ID:
2WNC
Keywords:
Title:
Crystal structure of Aplysia ACHBP in complex with tropisetron
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2009-07-08
Release Date:
2009-09-01
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
I 2 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Soluble acetylcholine receptor
Chain IDs:A, B, C, D, E
Chain Length:227
Number of Molecules:5
Biological Source:Aplysia californica
Ligand Molecules
Primary Citation
Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
EMBO J. 28 3040 3051 (2009)
PMID: 19696737 DOI: 10.1038/emboj.2009.227

Abstact

The pentameric acetylcholine-binding protein (AChBP) is a soluble surrogate of the ligand binding domain of nicotinic acetylcholine receptors. Agonists bind within a nest of aromatic side chains contributed by loops C and F on opposing faces of each subunit interface. Crystal structures of Aplysia AChBP bound with the agonist anabaseine, two partial agonists selectively activating the alpha7 receptor, 3-(2,4-dimethoxybenzylidene)-anabaseine and its 4-hydroxy metabolite, and an indole-containing partial agonist, tropisetron, were solved at 2.7-1.75 A resolution. All structures identify the Trp 147 carbonyl oxygen as the hydrogen bond acceptor for the agonist-protonated nitrogen. In the partial agonist complexes, the benzylidene and indole substituent positions, dictated by tight interactions with loop F, preclude loop C from adopting the closed conformation seen for full agonists. Fluctuation in loop C position and duality in ligand binding orientations suggest molecular bases for partial agonism at full-length receptors. This study, while pointing to loop F as a major determinant of receptor subtype selectivity, also identifies a new template region for designing alpha7-selective partial agonists to treat cognitive deficits in mental and neurodegenerative disorders.

Legend

Protein

Chemical

Disease

Primary Citation of related structures